SlideShare a Scribd company logo
QUALITY MANAGEMENT SYSTEM (MQA-102T)
UNIT IV
Quality Risk Management - ICH Q9 Guidelines
Presented By
V. Manikandan,
Roll No. 2061050002,
M. Pharm (Pharmaceutical Quality Assurance) – I Year,
Batch : 2020-2022,
Department of Pharmacy,
Annamalai University.
Submitted to
Dr. K. Devi, M. Pharm., Ph. D,
Assistant Professor,
Department of Pharmacy,
Annamalai University.
ICH Q9: Pharmaceutical Risk Management
1. Introduction
• The importance of quality systems has been recognized in the pharmaceutical industry and it is becoming
evident that quality risk management is a valuable component of an effective quality system.
• The purpose of this document is to offer a systematic approach to quality risk management.
• It specifically provides guidance on the principles and some of the tools of quality risk management that can
enable more effective and consistent risk-based decisions, both by regulators and industry, regarding the quality
of drug substances and drug (medicinal) products across the product lifecycle.
• An effective quality risk management approach can further ensure the high quality of the drug (medicinal)
product to the patient by providing a proactive means to identify and control potential quality issues during
development and manufacturing.
• Additionally, use of quality risk management can improve the decision making if a quality problem arises.
2. Risk Assessment
• Quality risk assessments begin with a well-defined problem description or risk question. When the risk in
question is well defined, an appropriate risk management tool and the types of information needed to address
the risk question will be more readily identifiable.
• As an aid to clearly defining the risk(s) for risk assessment purposes, three fundamental questions are often
helpful,
i. What might go wrong?
ii. What is the likelihood (probability) it will go wrong?
iii. What are the consequences (severity)?
• The output of a risk assessment is expressed in two methods,
i. Quantitative estimate of risk : expressed quantitatively, a numerical probability is used
ii. Qualitative description of risk: qualitative descriptors, such as “high”, “medium”, or “low”, which should
be defined in as much detail as possible
• Sometimes a "risk score" is used to further define descriptors in risk ranking.
3. Risk Control
• Risk control includes decision making to reduce and/or accept risks.
• The purpose of risk control is to reduce the risk to an acceptable level.
• The amount of effort used for risk control should be proportional to the significance of the risk.
• Decision makers might use different processes, including benefit-cost analysis, for understanding the optimal
level of risk control.
• Risk control might focus on the following questions:
i. Is the risk above an acceptable level?
ii. What can be done to reduce or eliminate risks?
iii. What is the appropriate balance among benefits, risks and resources?
iv. Are new risks introduced as a result of the identified risks being controlled?
• Risk reduction focuses on processes for mitigation or avoidance of quality risk when it exceeds a specified
(acceptable) level.
• Risk reduction might include actions taken to mitigate the severity and probability of harm.
• Processes that improve the detectability of hazards and quality risks might also be used as part of a risk control
strategy.
• The implementation of risk reduction measures can introduce new risks into the system or increase the
significance of other existing risks.
• Hence, it might be appropriate to revisit the risk assessment to identify and evaluate any possible change in risk
after implementing a risk reduction process.
• Risk acceptance is a decision to accept risk. Risk acceptance can be a formal decision to accept the residual risk
or it can be a passive decision in which residual risks are not specified.
• For some types of harms, even the best quality risk management practices might not entirely eliminate risk.
• In these circumstances, it might be agreed that an appropriate quality risk management strategy has been applied
and that quality risk is reduced to a specified (acceptable) level.
• This (specified) acceptable level will depend on many parameters and should be decided on a case-by-case basis.
4. Risk Review
• Risk management should be an ongoing part of the quality management process.
• A mechanism to review or monitor events should be implemented.
• Once a quality risk management process has been initiated, that process should continue to be utilized for events
that might impact the original quality risk management decision, whether these events are planned (e.g., results
of product review, inspections, audits, change control) or unplanned (e.g., root cause from failure investigations,
recall).
• The frequency of any review should be based upon the level of risk. Risk review might include reconsideration
of risk acceptance decisions (section 4.4).
5. Risk Assessment Tools
• Quality Risk management should be carried out based on the following principle
i. Evaluation of the risk to quality should be based on scientific knowledge and ultimately link to the
protection of the patient.
ii. Level of effort, formality and documentation of the quality risk management process should be appropriate
with the level of risk.
• The following risk assessment tools should be used for risk management process
i. Failure Mode Effects Analysis (FMEA)
ii. Failure Mode, Effects and Criticality Analysis (FMECA)
iii. Fault Tree Analysis (FTA)
iv. Hazard Analysis and Critical Control Points (HACCP)
v. Hazard Operability Analysis (HAZOP)
vi. Preliminary Hazard Analysis (PHA)
vii. Risk ranking and filtering
viii. Supporting statistical tools
6. Hazard Analysis and Critical Control Point (HACCP)
• HACCP technique is a systematic, proactive, and preventive method for assuring product quality, reliability and
safety . This technique would typically be applied for the following potential area of use,
i. To identify and manage risks associated with physical, chemical and biological hazards (including
microbiological contamination)
ii. Useful when process understanding is sufficiently comprehensive to support identification of critical
control points (critical parameters variables)
iii. iii. Facilitates monitoring of critical points in the manufacturing process.
• HACCP should be performed as per the following procedure,
i. Conduct hazard analysis: identify preventive measures for each step of the process
ii. Determine critical control points (CCPs)
iii. Establish target levels and critical limit(s)
iv. Establish system to monitor the CCPs
v. Establish corrective actions to be taken, if CCP is out of control
vi. Establish verification procedures, that HACCP works effectively vii. Establish documentation of all
procedures and keep records
7. Risk Ranking and Filtering
• Risk ranking and filtering is a tool for comparing and ranking risks. Risk ranking of complex systems typically
requires evaluation of multiple diverse quantitative and qualitative factors for each risk.
• The tool involves breaking down a basic risk question into as many components as needed to capture factors
involved in the risk.
• These factors are combined into a single relative risk score that can then be used for ranking risks. “Filters,” in
the form of weighting factors or cut-offs for risk scores, can be used to scale or fit the risk ranking to
management or policy objectives.
• Potential Areas of Use(s)
• Risk ranking and filtering can be used to prioritize manufacturing sites for inspection/audit by regulators or
industry.
• Risk ranking methods are particularly helpful in situations in which the portfolio of risks and the underlying
consequences to be managed are diverse and difficult to compare using a single tool.
• Risk ranking is useful when management needs to evaluate both quantitatively-assessed and qualitatively-
assessed risks within the same organizational framework.
REFERENCES
 https://www.ich.org (ICH Quality Guidelines)
• Q9 – Pharmaceutical Risk Management
THANK YOU

More Related Content

What's hot

Vendor Audites
Vendor AuditesVendor Audites
Vendor Audites
Nikita Amane
 
Change control oos oot
Change control oos ootChange control oos oot
Change control oos oot
AMOGH DANDEKAR
 
Vendor qualification
Vendor qualificationVendor qualification
Vendor qualification
ShihabPatel
 
Critical Hazard Management System (CHMS)
Critical Hazard Management System (CHMS)Critical Hazard Management System (CHMS)
Critical Hazard Management System (CHMS)
AnkitVasoya5
 
ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Management
muna_ali
 
Auditing of vendors and production department
Auditing of vendors and production departmentAuditing of vendors and production department
Auditing of vendors and production department
PRANJAY PATIL
 
Batch Review And Batch Release.pptx
Batch Review And Batch Release.pptxBatch Review And Batch Release.pptx
Batch Review And Batch Release.pptx
AbhishekJadhav189260
 
Auditing in Solid Oral Dosage Form Production Department
Auditing in Solid Oral Dosage Form Production DepartmentAuditing in Solid Oral Dosage Form Production Department
Auditing in Solid Oral Dosage Form Production Department
SANJAY KUMAR PUROHIT
 
Quality System and Audit.pptx
Quality System and Audit.pptxQuality System and Audit.pptx
Quality System and Audit.pptx
Dr. Dinesh Mehta
 
change control
change controlchange control
change control
SrinivasaReddy137
 
Quality Systems Approach Overview
Quality Systems Approach OverviewQuality Systems Approach Overview
Quality Systems Approach Overview
Mitchell Manning Sr.
 
ICH Q10 guideline.pptx
ICH Q10 guideline.pptxICH Q10 guideline.pptx
ICH Q10 guideline.pptx
02AishwaryaV
 
Pharmaceutical inspection convention M. Pharmacy
Pharmaceutical inspection convention M. PharmacyPharmaceutical inspection convention M. Pharmacy
Pharmaceutical inspection convention M. Pharmacy
priyankapatil7896
 
Role of quality systems and audits in pharmaceutical manufacturing environment
Role of quality systems and audits in pharmaceutical manufacturing environmentRole of quality systems and audits in pharmaceutical manufacturing environment
Role of quality systems and audits in pharmaceutical manufacturing environment
Malay Pandya
 
Six system inspection model.
Six system inspection model.Six system inspection model.
Six system inspection model.
VikramMadane1
 
Six system inspection model
Six system inspection modelSix system inspection model
Six system inspection model
Vaishali Dandge
 
Auditing of vendors and production department
Auditing of vendors and production departmentAuditing of vendors and production department
Auditing of vendors and production department
ArpitSuralkar
 
Air circulation maintenance industry for sterile and non sterile area
Air circulation maintenance  industry for sterile and non sterile areaAir circulation maintenance  industry for sterile and non sterile area
Air circulation maintenance industry for sterile and non sterile area
GNIPST
 
Auditing for Sterile Production Area
Auditing for Sterile Production AreaAuditing for Sterile Production Area
Auditing for Sterile Production Area
MANIKANDAN V
 
aseptic process technology
 aseptic process technology aseptic process technology
aseptic process technology
PRANJAY PATIL
 

What's hot (20)

Vendor Audites
Vendor AuditesVendor Audites
Vendor Audites
 
Change control oos oot
Change control oos ootChange control oos oot
Change control oos oot
 
Vendor qualification
Vendor qualificationVendor qualification
Vendor qualification
 
Critical Hazard Management System (CHMS)
Critical Hazard Management System (CHMS)Critical Hazard Management System (CHMS)
Critical Hazard Management System (CHMS)
 
ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Management
 
Auditing of vendors and production department
Auditing of vendors and production departmentAuditing of vendors and production department
Auditing of vendors and production department
 
Batch Review And Batch Release.pptx
Batch Review And Batch Release.pptxBatch Review And Batch Release.pptx
Batch Review And Batch Release.pptx
 
Auditing in Solid Oral Dosage Form Production Department
Auditing in Solid Oral Dosage Form Production DepartmentAuditing in Solid Oral Dosage Form Production Department
Auditing in Solid Oral Dosage Form Production Department
 
Quality System and Audit.pptx
Quality System and Audit.pptxQuality System and Audit.pptx
Quality System and Audit.pptx
 
change control
change controlchange control
change control
 
Quality Systems Approach Overview
Quality Systems Approach OverviewQuality Systems Approach Overview
Quality Systems Approach Overview
 
ICH Q10 guideline.pptx
ICH Q10 guideline.pptxICH Q10 guideline.pptx
ICH Q10 guideline.pptx
 
Pharmaceutical inspection convention M. Pharmacy
Pharmaceutical inspection convention M. PharmacyPharmaceutical inspection convention M. Pharmacy
Pharmaceutical inspection convention M. Pharmacy
 
Role of quality systems and audits in pharmaceutical manufacturing environment
Role of quality systems and audits in pharmaceutical manufacturing environmentRole of quality systems and audits in pharmaceutical manufacturing environment
Role of quality systems and audits in pharmaceutical manufacturing environment
 
Six system inspection model.
Six system inspection model.Six system inspection model.
Six system inspection model.
 
Six system inspection model
Six system inspection modelSix system inspection model
Six system inspection model
 
Auditing of vendors and production department
Auditing of vendors and production departmentAuditing of vendors and production department
Auditing of vendors and production department
 
Air circulation maintenance industry for sterile and non sterile area
Air circulation maintenance  industry for sterile and non sterile areaAir circulation maintenance  industry for sterile and non sterile area
Air circulation maintenance industry for sterile and non sterile area
 
Auditing for Sterile Production Area
Auditing for Sterile Production AreaAuditing for Sterile Production Area
Auditing for Sterile Production Area
 
aseptic process technology
 aseptic process technology aseptic process technology
aseptic process technology
 

Similar to ICH Q9 Guidelines

ICH Q9.pptx
ICH Q9.pptxICH Q9.pptx
ICH Q9.pptx
Venugopal N
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
Sandhya Ganapathiraju
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
KarunaMane1
 
Quality Risk Management.pptx
Quality Risk Management.pptxQuality Risk Management.pptx
Quality Risk Management.pptx
SyedMohammadRahat
 
Quality management system(qrm)
Quality management system(qrm)Quality management system(qrm)
Quality management system(qrm)
DPSRU,NEW DELHI
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
imran bakshi
 
ICH Q9 QUALITY RISK MANAGEMENT(QRM)
ICH Q9 QUALITY RISK MANAGEMENT(QRM)ICH Q9 QUALITY RISK MANAGEMENT(QRM)
ICH Q9 QUALITY RISK MANAGEMENT(QRM)
saimsoleja
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
Ezekiel Kilimo
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
praveen dubey
 
Risk Based Thinking - RMSP "RISK MANAGEMENT SYSTEM PROCESS"
Risk Based Thinking - RMSP "RISK MANAGEMENT SYSTEM PROCESS"Risk Based Thinking - RMSP "RISK MANAGEMENT SYSTEM PROCESS"
Risk Based Thinking - RMSP "RISK MANAGEMENT SYSTEM PROCESS"
Eng. A.karam Al Malkawi
 
Seminar on Quality Risk Management by Parag Ghadigaonkar
Seminar on Quality Risk Management by Parag GhadigaonkarSeminar on Quality Risk Management by Parag Ghadigaonkar
Seminar on Quality Risk Management by Parag Ghadigaonkar
ParagGhadigaonkar
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
NAVNATH K. GITE.
 
Risk management in pharmaceutical Industry
Risk management in pharmaceutical IndustryRisk management in pharmaceutical Industry
Risk management in pharmaceutical Industry
Mahesh shinde
 
QRM in drug analysis group Assignment.pptx
QRM in drug analysis group Assignment.pptxQRM in drug analysis group Assignment.pptx
QRM in drug analysis group Assignment.pptx
MichaelMohammed10
 
Keeping up with ICH E6(R2): Risk-Based Monitoring (RBM) Redefined
Keeping up with ICH E6(R2): Risk-Based Monitoring (RBM) RedefinedKeeping up with ICH E6(R2): Risk-Based Monitoring (RBM) Redefined
Keeping up with ICH E6(R2): Risk-Based Monitoring (RBM) Redefined
Life Sciences Network marcus evans
 
ICH-Q9 Fundamentals
ICH-Q9 FundamentalsICH-Q9 Fundamentals
ICH-Q9 Fundamentals
Obaid Ali / Roohi B. Obaid
 
Introduction to quality management system • Product quality review (PQR) • Qu...
Introduction to quality management system• Product quality review (PQR) • Qu...Introduction to quality management system• Product quality review (PQR) • Qu...
Introduction to quality management system • Product quality review (PQR) • Qu...
samahhamed3
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
Ashish Chaudhari
 
Hazards and risk management
Hazards and risk managementHazards and risk management
Hazards and risk management
saurastra university
 

Similar to ICH Q9 Guidelines (20)

ICH Q9.pptx
ICH Q9.pptxICH Q9.pptx
ICH Q9.pptx
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
 
Quality Risk Management.pptx
Quality Risk Management.pptxQuality Risk Management.pptx
Quality Risk Management.pptx
 
Quality management system(qrm)
Quality management system(qrm)Quality management system(qrm)
Quality management system(qrm)
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
 
ICH Q9 QUALITY RISK MANAGEMENT(QRM)
ICH Q9 QUALITY RISK MANAGEMENT(QRM)ICH Q9 QUALITY RISK MANAGEMENT(QRM)
ICH Q9 QUALITY RISK MANAGEMENT(QRM)
 
Presentation on QRM_NS
Presentation on QRM_NSPresentation on QRM_NS
Presentation on QRM_NS
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
 
Risk Based Thinking - RMSP "RISK MANAGEMENT SYSTEM PROCESS"
Risk Based Thinking - RMSP "RISK MANAGEMENT SYSTEM PROCESS"Risk Based Thinking - RMSP "RISK MANAGEMENT SYSTEM PROCESS"
Risk Based Thinking - RMSP "RISK MANAGEMENT SYSTEM PROCESS"
 
Seminar on Quality Risk Management by Parag Ghadigaonkar
Seminar on Quality Risk Management by Parag GhadigaonkarSeminar on Quality Risk Management by Parag Ghadigaonkar
Seminar on Quality Risk Management by Parag Ghadigaonkar
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
 
Risk management in pharmaceutical Industry
Risk management in pharmaceutical IndustryRisk management in pharmaceutical Industry
Risk management in pharmaceutical Industry
 
QRM in drug analysis group Assignment.pptx
QRM in drug analysis group Assignment.pptxQRM in drug analysis group Assignment.pptx
QRM in drug analysis group Assignment.pptx
 
Keeping up with ICH E6(R2): Risk-Based Monitoring (RBM) Redefined
Keeping up with ICH E6(R2): Risk-Based Monitoring (RBM) RedefinedKeeping up with ICH E6(R2): Risk-Based Monitoring (RBM) Redefined
Keeping up with ICH E6(R2): Risk-Based Monitoring (RBM) Redefined
 
ICH-Q9 Fundamentals
ICH-Q9 FundamentalsICH-Q9 Fundamentals
ICH-Q9 Fundamentals
 
Introduction to quality management system • Product quality review (PQR) • Qu...
Introduction to quality management system• Product quality review (PQR) • Qu...Introduction to quality management system• Product quality review (PQR) • Qu...
Introduction to quality management system • Product quality review (PQR) • Qu...
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
 
Hazards and risk management
Hazards and risk managementHazards and risk management
Hazards and risk management
 

More from MANIKANDAN V

Literature Review and Bibliography
Literature Review and BibliographyLiterature Review and Bibliography
Literature Review and Bibliography
MANIKANDAN V
 
Quality by Design and Process Analytical Technology
Quality by Design and Process Analytical TechnologyQuality by Design and Process Analytical Technology
Quality by Design and Process Analytical Technology
MANIKANDAN V
 
Hazards and Risk Management
Hazards and Risk ManagementHazards and Risk Management
Hazards and Risk Management
MANIKANDAN V
 
Fire and Explosion
Fire and ExplosionFire and Explosion
Fire and Explosion
MANIKANDAN V
 
Chemical Hazards
Chemical HazardsChemical Hazards
Chemical Hazards
MANIKANDAN V
 
Fire Prevention and Protection
Fire Prevention and ProtectionFire Prevention and Protection
Fire Prevention and Protection
MANIKANDAN V
 
Preliminary Hazard Analysis
Preliminary Hazard AnalysisPreliminary Hazard Analysis
Preliminary Hazard Analysis
MANIKANDAN V
 
Natural Resources
Natural ResourcesNatural Resources
Natural Resources
MANIKANDAN V
 
SUPAC, BACPAC, Post Marketing Surveillance
SUPAC, BACPAC, Post Marketing SurveillanceSUPAC, BACPAC, Post Marketing Surveillance
SUPAC, BACPAC, Post Marketing Surveillance
MANIKANDAN V
 
Principles of Drug Discovery and Development
Principles of Drug Discovery and DevelopmentPrinciples of Drug Discovery and Development
Principles of Drug Discovery and Development
MANIKANDAN V
 
IND, NDA, ANDA, SNDA
IND, NDA, ANDA, SNDAIND, NDA, ANDA, SNDA
IND, NDA, ANDA, SNDA
MANIKANDAN V
 
IPQC Test for Liquid Dosage Forms
IPQC Test for Liquid Dosage FormsIPQC Test for Liquid Dosage Forms
IPQC Test for Liquid Dosage Forms
MANIKANDAN V
 
cGMP Guidelines according to USFDA
cGMP Guidelines according to USFDAcGMP Guidelines according to USFDA
cGMP Guidelines according to USFDA
MANIKANDAN V
 
Overview of ICH Guidelines, CPCSEA
Overview of ICH Guidelines, CPCSEA Overview of ICH Guidelines, CPCSEA
Overview of ICH Guidelines, CPCSEA
MANIKANDAN V
 
ICH Stability Guidelines
ICH Stability GuidelinesICH Stability Guidelines
ICH Stability Guidelines
MANIKANDAN V
 
ICH Q8 Guidelines
ICH Q8 GuidelinesICH Q8 Guidelines
ICH Q8 Guidelines
MANIKANDAN V
 

More from MANIKANDAN V (16)

Literature Review and Bibliography
Literature Review and BibliographyLiterature Review and Bibliography
Literature Review and Bibliography
 
Quality by Design and Process Analytical Technology
Quality by Design and Process Analytical TechnologyQuality by Design and Process Analytical Technology
Quality by Design and Process Analytical Technology
 
Hazards and Risk Management
Hazards and Risk ManagementHazards and Risk Management
Hazards and Risk Management
 
Fire and Explosion
Fire and ExplosionFire and Explosion
Fire and Explosion
 
Chemical Hazards
Chemical HazardsChemical Hazards
Chemical Hazards
 
Fire Prevention and Protection
Fire Prevention and ProtectionFire Prevention and Protection
Fire Prevention and Protection
 
Preliminary Hazard Analysis
Preliminary Hazard AnalysisPreliminary Hazard Analysis
Preliminary Hazard Analysis
 
Natural Resources
Natural ResourcesNatural Resources
Natural Resources
 
SUPAC, BACPAC, Post Marketing Surveillance
SUPAC, BACPAC, Post Marketing SurveillanceSUPAC, BACPAC, Post Marketing Surveillance
SUPAC, BACPAC, Post Marketing Surveillance
 
Principles of Drug Discovery and Development
Principles of Drug Discovery and DevelopmentPrinciples of Drug Discovery and Development
Principles of Drug Discovery and Development
 
IND, NDA, ANDA, SNDA
IND, NDA, ANDA, SNDAIND, NDA, ANDA, SNDA
IND, NDA, ANDA, SNDA
 
IPQC Test for Liquid Dosage Forms
IPQC Test for Liquid Dosage FormsIPQC Test for Liquid Dosage Forms
IPQC Test for Liquid Dosage Forms
 
cGMP Guidelines according to USFDA
cGMP Guidelines according to USFDAcGMP Guidelines according to USFDA
cGMP Guidelines according to USFDA
 
Overview of ICH Guidelines, CPCSEA
Overview of ICH Guidelines, CPCSEA Overview of ICH Guidelines, CPCSEA
Overview of ICH Guidelines, CPCSEA
 
ICH Stability Guidelines
ICH Stability GuidelinesICH Stability Guidelines
ICH Stability Guidelines
 
ICH Q8 Guidelines
ICH Q8 GuidelinesICH Q8 Guidelines
ICH Q8 Guidelines
 

Recently uploaded

Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 

Recently uploaded (20)

Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 

ICH Q9 Guidelines

  • 1. QUALITY MANAGEMENT SYSTEM (MQA-102T) UNIT IV Quality Risk Management - ICH Q9 Guidelines Presented By V. Manikandan, Roll No. 2061050002, M. Pharm (Pharmaceutical Quality Assurance) – I Year, Batch : 2020-2022, Department of Pharmacy, Annamalai University. Submitted to Dr. K. Devi, M. Pharm., Ph. D, Assistant Professor, Department of Pharmacy, Annamalai University.
  • 2. ICH Q9: Pharmaceutical Risk Management 1. Introduction • The importance of quality systems has been recognized in the pharmaceutical industry and it is becoming evident that quality risk management is a valuable component of an effective quality system. • The purpose of this document is to offer a systematic approach to quality risk management. • It specifically provides guidance on the principles and some of the tools of quality risk management that can enable more effective and consistent risk-based decisions, both by regulators and industry, regarding the quality of drug substances and drug (medicinal) products across the product lifecycle. • An effective quality risk management approach can further ensure the high quality of the drug (medicinal) product to the patient by providing a proactive means to identify and control potential quality issues during development and manufacturing. • Additionally, use of quality risk management can improve the decision making if a quality problem arises.
  • 3. 2. Risk Assessment • Quality risk assessments begin with a well-defined problem description or risk question. When the risk in question is well defined, an appropriate risk management tool and the types of information needed to address the risk question will be more readily identifiable. • As an aid to clearly defining the risk(s) for risk assessment purposes, three fundamental questions are often helpful, i. What might go wrong? ii. What is the likelihood (probability) it will go wrong? iii. What are the consequences (severity)? • The output of a risk assessment is expressed in two methods, i. Quantitative estimate of risk : expressed quantitatively, a numerical probability is used ii. Qualitative description of risk: qualitative descriptors, such as “high”, “medium”, or “low”, which should be defined in as much detail as possible • Sometimes a "risk score" is used to further define descriptors in risk ranking.
  • 4. 3. Risk Control • Risk control includes decision making to reduce and/or accept risks. • The purpose of risk control is to reduce the risk to an acceptable level. • The amount of effort used for risk control should be proportional to the significance of the risk. • Decision makers might use different processes, including benefit-cost analysis, for understanding the optimal level of risk control. • Risk control might focus on the following questions: i. Is the risk above an acceptable level? ii. What can be done to reduce or eliminate risks? iii. What is the appropriate balance among benefits, risks and resources? iv. Are new risks introduced as a result of the identified risks being controlled? • Risk reduction focuses on processes for mitigation or avoidance of quality risk when it exceeds a specified (acceptable) level. • Risk reduction might include actions taken to mitigate the severity and probability of harm.
  • 5. • Processes that improve the detectability of hazards and quality risks might also be used as part of a risk control strategy. • The implementation of risk reduction measures can introduce new risks into the system or increase the significance of other existing risks. • Hence, it might be appropriate to revisit the risk assessment to identify and evaluate any possible change in risk after implementing a risk reduction process. • Risk acceptance is a decision to accept risk. Risk acceptance can be a formal decision to accept the residual risk or it can be a passive decision in which residual risks are not specified. • For some types of harms, even the best quality risk management practices might not entirely eliminate risk. • In these circumstances, it might be agreed that an appropriate quality risk management strategy has been applied and that quality risk is reduced to a specified (acceptable) level. • This (specified) acceptable level will depend on many parameters and should be decided on a case-by-case basis.
  • 6. 4. Risk Review • Risk management should be an ongoing part of the quality management process. • A mechanism to review or monitor events should be implemented. • Once a quality risk management process has been initiated, that process should continue to be utilized for events that might impact the original quality risk management decision, whether these events are planned (e.g., results of product review, inspections, audits, change control) or unplanned (e.g., root cause from failure investigations, recall). • The frequency of any review should be based upon the level of risk. Risk review might include reconsideration of risk acceptance decisions (section 4.4). 5. Risk Assessment Tools • Quality Risk management should be carried out based on the following principle i. Evaluation of the risk to quality should be based on scientific knowledge and ultimately link to the protection of the patient. ii. Level of effort, formality and documentation of the quality risk management process should be appropriate with the level of risk.
  • 7. • The following risk assessment tools should be used for risk management process i. Failure Mode Effects Analysis (FMEA) ii. Failure Mode, Effects and Criticality Analysis (FMECA) iii. Fault Tree Analysis (FTA) iv. Hazard Analysis and Critical Control Points (HACCP) v. Hazard Operability Analysis (HAZOP) vi. Preliminary Hazard Analysis (PHA) vii. Risk ranking and filtering viii. Supporting statistical tools 6. Hazard Analysis and Critical Control Point (HACCP) • HACCP technique is a systematic, proactive, and preventive method for assuring product quality, reliability and safety . This technique would typically be applied for the following potential area of use, i. To identify and manage risks associated with physical, chemical and biological hazards (including microbiological contamination)
  • 8. ii. Useful when process understanding is sufficiently comprehensive to support identification of critical control points (critical parameters variables) iii. iii. Facilitates monitoring of critical points in the manufacturing process. • HACCP should be performed as per the following procedure, i. Conduct hazard analysis: identify preventive measures for each step of the process ii. Determine critical control points (CCPs) iii. Establish target levels and critical limit(s) iv. Establish system to monitor the CCPs v. Establish corrective actions to be taken, if CCP is out of control vi. Establish verification procedures, that HACCP works effectively vii. Establish documentation of all procedures and keep records 7. Risk Ranking and Filtering • Risk ranking and filtering is a tool for comparing and ranking risks. Risk ranking of complex systems typically requires evaluation of multiple diverse quantitative and qualitative factors for each risk.
  • 9. • The tool involves breaking down a basic risk question into as many components as needed to capture factors involved in the risk. • These factors are combined into a single relative risk score that can then be used for ranking risks. “Filters,” in the form of weighting factors or cut-offs for risk scores, can be used to scale or fit the risk ranking to management or policy objectives. • Potential Areas of Use(s) • Risk ranking and filtering can be used to prioritize manufacturing sites for inspection/audit by regulators or industry. • Risk ranking methods are particularly helpful in situations in which the portfolio of risks and the underlying consequences to be managed are diverse and difficult to compare using a single tool. • Risk ranking is useful when management needs to evaluate both quantitatively-assessed and qualitatively- assessed risks within the same organizational framework.
  • 10. REFERENCES  https://www.ich.org (ICH Quality Guidelines) • Q9 – Pharmaceutical Risk Management